Filing Details
- Accession Number:
- 0001567619-21-008151
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-15 16:33:38
- Reporting Period:
- 2021-04-13
- Accepted Time:
- 2021-04-15 16:33:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1533743 | Processa Pharmaceuticals Inc. | PCSA | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1361896 | W Justin Yorke | C/O Processa Pharmaceuticals, Inc. 7380 Coca Cola Drive, Suite 106 Hanover MD 21076 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-04-13 | 6,500 | $9.86 | 257,972 | No | 4 | S | Indirect | By San Gabriel Fund, LLC, JMW Fund, LLC and the Richland Fund, LLC |
| Common Stock | Disposition | 2021-04-14 | 9,700 | $9.42 | 248,272 | No | 4 | S | Indirect | By San Gabriel Fund, LLC, JMW Fund, LLC and the Richland Fund, LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By San Gabriel Fund, LLC, JMW Fund, LLC and the Richland Fund, LLC |
| No | 4 | S | Indirect | By San Gabriel Fund, LLC, JMW Fund, LLC and the Richland Fund, LLC |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 300,706 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.65 to $10.15, inclusive. The Reporting Person undertakes to provide Processa Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.31 to $9.50, inclusive. The Reporting Person undertakes to provide Processa Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Billionaire Hedge Funds
